NAVA Navamedic ASA
13.05NOK-1.88%Mkt Cap: 29.25M $P/E: —1d ago
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includ…
Industry Peers
Medical DistributionKey Statistics
Company
Market Cap29.25M USD
Enterprise Value41.99M USD
Revenue (TTM)53.69M USD
Gross Profit20.60M USD
Net Income (TTM)-2.20M USD
Revenue/Share25.70 NOK
Last Price13.05 NOK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees38
CountryNO
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)42.56
PEG1.38
EV/EBITDA9.52
EV/Revenue0.78
P/S0.56
P/B1.04
EPS (TTM)-1.08
EPS (Forward)0.31
52W Range
13.050% of range26.50
52W High26.50 NOK
52W Low13.05 NOK
Profitability
Gross Margin38.97%
Oper. Margin1.10%
EBITDA Margin8.22%
Profit Margin-4.16%
ROE-7.05%
ROA-3.17%
Growth
Revenue Growth2.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.39M USD
CapEx (TTM)222.57K USD
FCF Margin5.51%
FCF Yield10.11%
Net Debt12.16M USD
Net Debt/EBITDA2.76
Balance Sheet
Debt/Equity0.68
Current Ratio1.47
Quick Ratio0.74
Book Value/Sh12.76 NOK
Cash/Share2.21 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 NOK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 13, 2010
Pay Date—
Analyst Consensus
Rating—
Target (Mean)21.00 NOK
Upside (mean)+60.9%
Target Range21.00 NOK – 21.00 NOK
# Analysts2
Ownership
Shares Out.23.98M
Float9.98M
Insiders69.50%
Institutions16.57%
Technical
SMA 5014.84 (-12.0%)
SMA 20018.47 (-29.3%)
Beta0.20
S&P 52W Chg14.58%
Avg Vol (30d)30.12K
Avg Vol (10d)10.81K
Technical Indicators
RSI (14)32.6
MACD-0.3580
MACD Signal-0.4386
MACD Hist.+0.0806
BB Upper13.81 NOK
BB Middle13.42 NOK
BB Lower13.04 NOK
BB Width5.75%
ATR (14)0.4057 NOK
Vol Ratio (20d)1.01x